The company claims that Dysport is now the first botulinum toxin therapy to demonstrate efficacy in episodic migraine.

Qelbree remains the first novel, non-stimulant ADHD medication approved in over a decade and is the only ADHD treatment with serotonin (5-HT2C) ...

In a first for the neurotoxin market, Ipsen announced Thursday that its Dysport has hit the goals in two phase 3 trials for ...

We’ve recommended cemiplimab (also called Libtayo and made by Regeneron) as an option for adults with recurrent or metastatic cervical cancer that has got worse during or after they’ve had ...

Some side effects of antipsychotics may not appear until years after treatment begins, making long-term monitoring an essential part of care.

Topline data from the phase 3 E-BEOND and C-BEOND trials show a significant reduction in monthly migraine days at 24 weeks, demonstrating efficacy across the full migraine spectrum.

After years of severe Tourette, Abigail Bailey saw her tics plummet following deep brain stimulation surgery at Allegheny ...